Czechia, June 1 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Antineoplastic agents Medicinal preparations containing inotuzumab ozogamicin trastuzumab nivolumab ipilimumab amivantanab mosunetuzumab . The value of the contract is worth 41405888260 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....